Austin W. Marxe & David M. Greenhouse’s Aratana Therapeutics, Inc. PETX Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$6.02M	Hold	600,000	–	–	0.82%	42
2014 Q2	$9.37M	Hold	600,000	–	–	1.19%	30
2014 Q1	$11.1M	Sell	600,000 -100,000	-14%	-$2M	1.23%	22
2013 Q4	$13.4M	Sell	700,000 -60,590	-8%	-$1.23M	1.43%	20
2013 Q3	$12.4M	Sell	760,590 -5,850	-0.8%	-$61.5K	1.53%	21
2013 Q2	$5.79M	Buy	+766,440	New	+$6.06M	0.78%	46

Other funds holding PETX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's PETX Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse held its Aratana Therapeutics, Inc. (PETX) position steady in Q3 2014 at 600,000 shares worth $6.02M. The position accounts for 0.82% of the portfolio, ranked #42.

Austin W. Marxe & David M. Greenhouse first reported a position in PETX in Q2 2013 and has held it in 6 quarters since. The position peaked at $13.4M in Q4 2013. 82 funds tracked by Wall St. Rank hold PETX as of Q3 2014.

Austin W. Marxe & David M. Greenhouse held 600,000 shares of Aratana Therapeutics, Inc. worth $6.02M as of Q3 2014.
Austin W. Marxe & David M. Greenhouse left its Aratana Therapeutics, Inc. share count unchanged in Q3 2014.
Aratana Therapeutics, Inc. made up 0.82% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #42 holding.
Austin W. Marxe & David M. Greenhouse first reported a position in Aratana Therapeutics, Inc. in Q2 2013 and has held it in 6 quarters since.
Austin W. Marxe & David M. Greenhouse's Aratana Therapeutics, Inc. position peaked at $13.4M in Q4 2013.
82 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.